Dr. Robert W. Spech, M.D.
Pulmonology (Pulmonary Disease Physician)
- Medicare participating
At a glance
- Medical school
- Ohio State University College of Medicine (1990)
- Years since graduation
- 36
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 277
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1990Medical school: Ohio State University College of Medicine
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pulmonary Disease Physician primary
IN license 01060066A -
Critical Care Medicine (Internal Medicine) Physician
IN license 01060066A
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Indiana University Health Indianapolis, IN
- Indiana University Health North Hospital Carmel, IN
- Indiana University Health Tipton Hospital Inc Tipton, IN
Medical groups
- Iu Health Medical Group LLC (4,462 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 277
- Services billed
- 790
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 144 | 114 |
| Critical care, first 30-74 minutes | 69 | 31 |
| Established patient office or other outpatient visit, 30-39 minutes | 63 | 50 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 60 | 32 |
| New patient office or other outpatient visit, 45-59 minutes | 50 | 50 |
| Test to examine how well the lungs exchange gases | 49 | 48 |
| Test to determine lung volumes using sensors | 46 | 45 |
| Test to measure expiratory airflow and volume | 42 | 42 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 41 | 41 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 34 | 18 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Indianapolis, IN | 341 |
| Trelegy Ellipta (fluticasone/umeclidin/vilanter) Other prescribers in Indianapolis, IN | 308 |
| Breo Ellipta (fluticasone/vilanterol) Other prescribers in Indianapolis, IN | 120 |
| Montelukast Sodium Other prescribers in Indianapolis, IN | 111 |
| Arnuity Ellipta (fluticasone furoate) Other prescribers in Indianapolis, IN | 75 |
| Azithromycin Other prescribers in Indianapolis, IN | 66 |
| Symbicort (budesonide/formoterol fumarate) Other prescribers in Indianapolis, IN | 65 |
| Stiolto Respimat (tiotropium br/olodaterol hcl) Other prescribers in Indianapolis, IN | 64 |
| Prednisone Other prescribers in Indianapolis, IN | 64 |
| Anoro Ellipta (umeclidinium brm/vilanterol tr) Other prescribers in Indianapolis, IN | 61 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 3 companies reported 16 payments worth $238 in total to this clinician.
| Insmed, Inc. | $184 |
|---|---|
| GlaxoSmithKline, LLC. | $36.25 |
| Genzyme Corporation | $17.57 |
| Food and Beverage | $238 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.